| | □控股股东/实际控制人及其一致行动人 ☑其他 5%以上大股东及其一致行动人 | | --- | --- | | 投资者及其一致行动人的身份 | □合并口径第一大股东及其一致行动人（仅适用 | | | 于无控股股东、实际控制人） | | | □其他______________（请注明） | 证券代码：688550 证券简称：瑞联新材 公告编号：2025-057 西安瑞联新材料股份有限公司 关于持股 5%以上股东之一致行动人权益变动触及 1%刻度的提示性公告 刘晓春及其一致行动人西安鑫宙新材料有限责任公司、王小伟、王银彬保证向本 公司提供的信息真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： | 权益变动方向 | 比例增加☑ | | 比例减少□ | | --- | --- | --- | --- | | 权益变动前合计比例 | 15.00% | | | | 权益变动后合计比例 | 16.82% | | | | 本次变动是否违反已作出的承 | 是□ | 否☑ | | | 诺、意向、计划 | | | | | 是否触发强制 ...

Investment Rating - The report maintains a "Buy" rating for the company, with an expected relative return of over 20% within the next six months [6][18]. Core Insights - The company achieved a revenue of 1.459 billion yuan in 2024, representing a year-on-year increase of 20.7%, and a net profit attributable to the parent company of 252 million yuan, up 87.6% year-on-year [1][2]. - The display materials segment has become the largest business area for the company, driven by the increasing penetration of OLED panels in medium and large-sized screens [2][3]. - The pharmaceutical segment is focusing on stable supply and new product development amidst a competitive market, with a total of 271 drug pipelines by the end of 2024, an increase of 64 from the previous year [2][3]. - The electronic materials segment faced challenges due to technological substitutions and cautious customer procurement strategies, leading to a decline in sales, although the number of products sold increased by 72% year-on-year [3]. - The overall gross margin for 2024 was 44.20%, an increase of 9.02 percentage points from 2023, attributed to product mix optimization and effective cost control measures [3]. Financial Summary - The company forecasts net profits of 313 million yuan, 367 million yuan, and 400 million yuan for 2025, 2026, and 2027 respectively, reflecting an upward revision from previous estimates [3]. - The projected revenue growth rates for the next few years are 36.93% for 2025, 20.53% for 2026, and 6.90% for 2027 [5][12]. - The earnings per share (EPS) are expected to increase from 1.46 yuan in 2024 to 2.32 yuan in 2027 [5][12].

证券代码：688550 证券简称：瑞联新材 公告编号：2025-057 西安瑞联新材料股份有限公司 关于持股 5%以上股东之一致行动人权益变动触及 刘晓春及其一致行动人西安鑫宙新材料有限责任公司、王小伟、王银彬保证向本 公司提供的信息真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 权益变动方向 比例增加? 比例减少□ 权益变动前合计比例 15.00% 权益变动后合计比例 16.82% 本次变动是否违反已作出的承 是□ 否? 诺、意向、计划 是否触发强制要约收购义务 是□ 否? 一、 信息披露义务人及其一致行动人的基本信息 □控股股东/实际控制人及其一致行动人 ?其他 5%以上大股东及其一致行动人 投资者及其一致行动人的身份 □合并口径第一大股东及其一致行动人（仅适用 于无控股股东、实际控制人） □其他______________（请注明） 信息披露义务人名称 投资者身份 统一社会信用代码 □ 控股股东/实控人 西安鑫宙新材料有限 □ 控股股东/实控人的一致 ?91610131MAE7M7G0XP 责任公司 行动人 □ ...

证券代码：688550 证券简称：瑞联新材 公告编号：2025-056 驳回开投集团关于二审诉讼费用由刘晓春承担的请求；2、驳回上诉人刘晓春"撤 销原判，依法将本案发回重审或改判驳回开投集团的全部诉讼请求"的请求，驳回 刘晓春关于本案一、二审的诉讼费用由开投集团承担的请求。 ? 对上市公司的影响：本次诉讼系公司持股 5%以上股东开投集团和刘晓春之 间的股权转让纠纷，本次诉讼不会对公司生产经营产生重大影响。本次判决为终审 判决，自上诉人收到判决书之日起生效，双方是否继续进行申诉及后续执行情况 尚存在不确定性。 西安瑞联新材料股份有限公司 关于持股 5%以上股东股权转让纠纷 二审判决结果的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 案件所处的诉讼阶段：二审已判决，为终审判决 ? 诉讼当事人：上诉人（原审原告）持股 5%以上股东青岛开发区投资建设集 团有限公司（下称"开投集团" ）、上诉人（原审被告）持股 5%以上股东刘晓春 ? 二审判决结果主要内容：1、驳回上诉人开投集团"撤销原判第四项，改判 刘 ...

证券代码：688550 证券简称：瑞联新材 公告编号：2025-056 西安瑞联新材料股份有限公司 关于持股 5%以上股东股权转让纠纷 二审判决结果的公告 重要内容提示： 案件所处的诉讼阶段：二审已判决，为终审判决 诉讼当事人：上诉人（原审原告）持股 5%以上股东青岛开发区投资建设集 团有限公司（下称"开投集团"）、上诉人（原审被告）持股 5%以上股东刘晓春 二审判决结果主要内容：1、驳回上诉人开投集团"撤销原判第四项，改判 刘晓春于判决生效后十日内支付开投集团已承担全部律师费527,340.24元"的请求； 驳回开投集团关于二审诉讼费用由刘晓春承担的请求；2、驳回上诉人刘晓春"撤 销原判，依法将本案发回重审或改判驳回开投集团的全部诉讼请求"的请求，驳回 刘晓春关于本案一、二审的诉讼费用由开投集团承担的请求。 对上市公司的影响：本次诉讼系公司持股 5%以上股东开投集团和刘晓春之 间的股权转让纠纷，本次诉讼不会对公司生产经营产生重大影响。本次判决为终审 判决，自上诉人收到判决书之日起生效，双方是否继续进行申诉及后续执行情况 尚存在不确定性。 西安瑞联新材料股份有限公司（下称"瑞联新材"或"公司"）于近日收到持 ...

Mergers and Acquisitions - Cixing Co., Ltd. plans to acquire 75% of Shenyang Shunyi Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds from no more than 35 qualified investors [1] - United Optoelectronics intends to purchase 100% of Changyi Optoelectronics from 12 shareholders via share issuance and will also raise supporting funds [2] - Inte Group's subsidiary, Inte Pharmaceutical, successfully acquired 100% equity of Zhejiang Huadong Pharmaceutical Group Co., Ltd. for 369 million yuan and signed a transaction contract with the transferor [3] Shareholding Changes - Guokang Biochemical announced that shareholders plan to collectively reduce their holdings by no more than 6% of the company's total shares, with specific plans from two major shareholders to reduce by 3% each [4] - Ruilian New Materials reported that a major shareholder, Guofu Yongyu, plans to reduce its holdings by up to 3.33%, equivalent to 573,110 shares [5] - Hongxin Technology disclosed that two major shareholders, Baiqiang and Taizhou Qixin, plan to reduce their holdings by 2.62% and 2.12% respectively [6] Risk Matters - Sinovac Biotech highlighted the high-tech, high-risk, and high-value characteristics of its innovative drugs, emphasizing the uncertainties involved in the research and approval processes [7] - Zhongheng Design noted that the revenue from its low-altitude economy and commercial aerospace projects is minimal compared to its consolidated financial statements, despite winning several contracts in these sectors [8] Restructuring - *ST Xinyan announced that it received a notice from a creditor applying for the company's restructuring and pre-restructuring procedures [10]

西安瑞联新材料股份有限公司 证券代码：688550 证券简称：瑞联新材 公告编号：2025-055 持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 截至本公告披露日，西安瑞联新材料股份有限公司（以下简称"公司"）股 东宁波国富永钰创业投资合伙企业（有限合伙）（以下简称"国富永钰"）持有公 司 14,309,565 股股份，占公司总股本的 8.31%，非公司第一大股东。 上述股份来源于国富永钰于公司首次公开发行前取得的股份及公司上市以 来实施权益分派资本公积金转增股本取得的股份，均为无限售条件流通股。 减持计划的主要内容 根据自身资金需要，国富永钰计划以集中竞价或大宗交易的方式进行减持， 预计减持股份不超过 5,731,100 股，占公司总股本的 3.33%。 股东通过集中竞价交易方式或大宗交易方式减持的，减持期间为自本公告披 露之日起 15 个交易日后的三个月内。 国富永钰系已在中国证券投资基金业协会完成备案的私募基金，并向中国证 券投资 ...

瑞联新材公告，持股5%以上股东国富永钰计划以集中竞价或大宗交易的方式减持股份不超过573.11万 股，占公司总股本的3.33%。 ...

Market Performance - The photoresist concept sector declined by 1.60%, ranking among the top declines in the concept sector as of the market close on May 28 [1] - Within the sector, stocks such as Guofeng New Materials, Xilong Science, and Kent Catalysts experienced significant declines, while 16 stocks saw price increases, with Ruile New Materials, Tongcheng New Materials, and Aolaide leading the gains at 5.08%, 2.99%, and 2.74% respectively [1] Capital Flow - The photoresist concept sector experienced a net outflow of 1.135 billion yuan, with 51 stocks seeing net outflows, and 7 stocks having outflows exceeding 50 million yuan [2] - The stock with the highest net outflow was Kaimete Gas, with a net outflow of 274 million yuan, followed by Hongbaoli, Feikai Materials, and Guofeng New Materials with net outflows of 198 million yuan, 115 million yuan, and 79.89 million yuan respectively [2] Top Gainers and Losers - The top gainers in the photoresist concept stocks included Tongcheng New Materials, Ruile New Materials, and Qicai Chemical, with net inflows of 37.81 million yuan, 36.54 million yuan, and 30.98 million yuan respectively [2][4] - The stocks with the largest declines included Kaimete Gas at -3.90%, Hongbaoli at -5.13%, and Feikai Materials at -4.16% [3][4]

Investment Rating - The report maintains a "Buy" rating for key companies in the chemical industry, specifically recommending Minsheng Chemical's "Five Tigers": Shengquan Group, Guocera Materials, Guoguang Co., Anli Co., and Polymeric Co. [1][4] Core Insights - The chemical market is active, with growth stocks presenting a favorable allocation opportunity. The demand for phosphate fertilizers remains stable, and the high price of phosphate rock is expected to continue due to supply-demand balance. [1] - The domestic production capacity of polycarbonate (PC) is projected to grow significantly from 875,000 tons in 2018 to 3,810,000 tons by 2024, with an expected improvement in supply-demand dynamics from 2025 to 2029. [2] - The organic silicon industry is experiencing a recovery in the supply-demand balance, with a compound annual growth rate of 22.4% in production capacity from 2021 to 2024, driven by demand from emerging industries such as new energy vehicles and photovoltaics. [2] Summary by Sections Chemical Market Overview - The basic chemical industry index closed at 3,406.53 points, down 1.23% from the previous week, underperforming the CSI 300 index by 1.05%. [10] - Among 462 stocks in the chemical sector, 31% rose while 67% fell during the week. [18] Key Chemical Sub-Industries - **Polyester Filament**: The market is stable with slight price increases, and the average industry operating rate is approximately 89.96%. [26][27] - **Tires**: The operating rate for all-steel tires is 60.12%, down 2.88 percentage points from the previous week. [40] - **Refrigerants**: Prices for refrigerants like R22 and R134a are stable to strong, with R22 averaging 36,000 CNY/ton and R134a at 48,000 CNY/ton. [45][47] Price Trends - The top price increases for chemical products include cotton short velvet (up 15%), trichloromethane (up 14%), and domestic naphtha (up 13%). [24] - Conversely, the largest price drops were seen in liquid chlorine (down 71%) and TMA (down 9%). [25] Company Profit Forecasts - Guoguang Co. is projected to have an EPS of 0.78 CNY in 2024, with a PE ratio of 19, while Shengquan Group is expected to have an EPS of 1.03 CNY with a PE ratio of 25. Both companies are rated as "Recommended." [4]